Marinus Pharmaceuticals Inc (MRNS) - Narxning prognoz qilingan daromadga nisbati
Ushbu GURU.Markets grafigidagi forward P/S tendentsiyasi 1.00 darajasida barqarorlashgan bo'lib, bu Ztalmy dori vositasining tijorat reklamasiga va global bozorlarga kengayishga bog'liqdir. Marinus Pharmaceuticals hozirda oral ganaxolone uchun tasdiqni olishni ta'minlash maqsadida xarajatlarni optimallashtirmoqda va R&D loyihalari ro'yxatini qisqartirmoqda. Marinus Pharmaceuticals daromadlari genetik epilepsiya dori vositalarining sotuvi va shifoxona darajasidagi farmatsevtika vositalarini ishlab chiqishga asoslangan.
marinuspharma.com (MRNS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Marinus Pharmaceuticals|MRNS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Marinus Pharmaceuticals Inc|MRNS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Marinus Pharmaceuticals|MRNS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Marinus Pharmaceuticals|Tezkor likvidlik koeffitsiyenti marinuspharma.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
MRNS - Kompaniyaning sof daromadi|Kelajakdagi foyda Marinus Pharmaceuticals|MRNS - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Marinus|MRNS - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Marinus|MRNS - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) Marinus Pharmaceuticals|MRNS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi marinuspharma.com|MRNS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Marinus Pharmaceuticals
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Marinus Pharmaceuticals Inc MRNS
Forward P/S koeffitsiyenti Marinus Pharmaceuticals (MRNS) bozor qiymatini prognoz qilingan daromadlar bilan solishtiradi, bu esa kelajakdagi o'sish uchun to'langan premiumni baholash va investitsiyaning xavfsizlik zaxirasini aniqlash imkonini beradi. Forward P/S tarixini tahlil qilish orqali investor steroid dori vositalari uchun patent himoyasi va tutqanoqqa qarshi dori vositalarining kamyob dori statusi qanday qilib generik kengayish xavflarini minimallashtirgan holda yuqori biznes baholashini qo'llab-quvvatlashini ko'rishi mumkin.
Marinus Pharmaceuticals raqobatchilari
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati cyclerion.com CYCN|Forvard P/S multiplikatori PTIX|KTTA - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|BCLI - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati caratherapeutics.com|CHRO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Longboard|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
